This Article Full Text Full Text (PDF) All Versions of this Article: 108/24/3031    most recent 01.CIR.0000101925.37174.85v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Niemann, J. T. Articles by Lewis, R. J. Search for Related Content PubMed PubMed Citation Articles by Niemann, J. T. Articles by Lewis, R. J. Related Collections CPR and emergency cardiac care

(Circulation. 2003;108:3031.)
© 2003 American Heart Association, Inc.

Basic Science Reports

Milrinone Facilitates Resuscitation From Cardiac Arrest and Attenuates Postresuscitation Myocardial Dysfunction

From Harbor-UCLA Medical Center, the Departments of Emergency Medicine and Medicine, Division of Cardiology (E.K.), and the David Geffen UCLA School of Medicine, Los Angeles, Calif.

Correspondence to James T. Niemann, MD, Harbor-UCLA Medical Center, Department of Emergency Medicine, Box 21, 1000 W Carson St, Torrance, CA 90509. E-mail jniemann{at}emedharbor.edu

Received January 9, 2003; de novo received June 9, 2003; revision received August 12, 2003; accepted August 14, 2003.

Background— Left ventricular (LV) dysfunction with a low cardiac index after successful CPR contributes to early death attributable to multiorgan failure, and an effective treatment has not been identified. The purpose of this study was to investigate the use of milrinone, a selective phosphodiesterase III inhibitor, as treatment for LV dysfunction after resuscitation.

Methods and Results— Ventricular fibrillation (VF) was induced electrically in 32 swine. After 5 minutes of VF, CPR was initiated and animals were randomized to receive either saline (control group, n=16) as a bolus and infusion or milrinone 50 µg/kg as a bolus and then 0.5 µg/kg per min for 60 minutes (treatment group, n=16). After 2 minutes of CPR (total VF time, 7 minutes), countershocks were given. Coronary perfusion pressures during CPR were similar for the groups (24±2 versus 21±4 mm Hg). All animals were defibrillated; 6 of 16 control animals developed refractory postcountershock pulseless electrical activity compared with 0 of 16 treated animals (P=0.018). At 30 minutes after restoration of spontaneous circulation, stroke volume (16±3 versus 26±7 mL, P<0.01) and LV dp/dt (793±197 versus 1108±316 mm Hg/s, P<0.02) were higher in the treatment group. Similar differences were observed 60 minutes after restoration of spontaneous circulation. Significant differences in heart rates between groups were not observed, and peripheral vascular resistance was significantly greater in the control group 30 and 60 minutes after resuscitation.

Conclusions— Milrinone facilitates resuscitation from prolonged VF and attenuates LV dysfunction after resuscitation without worsening major determinants of myocardial oxygen demand.

Key Words: heart arrest • cardiopulmonary resuscitation • drugs • contractility

This article has been cited by other articles:

				The International Liaison Committee on Resuscitati The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support Pediatrics, May 1, 2006; 117(5): e955 - e977. [Abstract] [Full Text] [PDF]

				Part 6: Pediatric Basic and Advanced Life Support Circulation, November 29, 2005; 112(22_suppl): III-73 - III-90. [Full Text] [PDF]

				A. A. El-Menyar The Resuscitation Outcome: Revisit the Story of the Stony Heart Chest, October 1, 2005; 128(4): 2835 - 2846. [Abstract] [Full Text] [PDF]